Related Experiment Videos
The role of the mucus gel layer in intestinal bacterial translocation
R T Maxson1, J P Dunlap, F Tryka
1Department of Surgery, University of Arkansas for Medical Sciences, Little Rock.
Insights
The intestinal mucus gel layer protects against bacterial translocation after ischemia and reoxygenation. Decreasing mucus production increased bacterial movement in an in vitro rat model.
Area of Science:
- Gastroenterology
- Microbiology
- Physiology
Background:
- The intestinal mucus gel layer is crucial for maintaining the mucosal barrier.
- Ischemia and reoxygenation can compromise intestinal integrity.
- Bacterial translocation is a concern in compromised gut barrier function.
Purpose of the Study:
- To investigate the role of mucus production in bacterial translocation following intestinal ischemia and reoxygenation.
- To determine if reduced mucus production exacerbates bacterial translocation.
- To assess the protective effect of the mucus layer in an in vitro model.
Main Methods:
- An in vitro rat mucosal model was utilized.
- Clonidine was administered to reduce mucus production.
- Ischemia and reoxygenation insult was induced.
- Bacterial translocation was measured using Escherichia coli K100 in a modified Ussing chamber.
Main Results:
- Clonidine treatment significantly decreased mucus production compared to controls.
- Animals with reduced mucus production exhibited higher bacterial translocation rates.
- The quantity of translocating bacteria was significantly greater in the clonidine group.
Conclusions:
- The mucus gel layer provides a protective barrier against bacterial translocation.
- Reduced mucus production compromises intestinal barrier function during ischemia/reoxygenation.
- Maintaining mucus integrity is vital for preventing bacterial translocation in the gut.
Abstract:
The mucus gel layer is thought to be a vital component of the intestinal mucosal barrier. The purpose of this study is to determine if decreasing mucus production following ischemia and reoxygenation of the intestinal mucosa would alter bacterial translocation in an in vitro rat mucosal model. Clonidine was used to decrease mucus production associated with an ischemia/reoxygenation insult. Bacterial translocation was studied in a modified Ussing chamber using Escherichia coli K100. The quantity of mucus produced, as well as the incidence and quantity of bacteria translocating was measured. In the clonidine-treated animals, there was a significant decrease in the amount of mucus produced compared to the control animals. The clonidine animals also had a higher quantity of bacteria translocating during the reoxygenation period compared to the control animals. The mucus gel layer is protective against in vitro translocation of bacteria following an ischemia/reoxygenation insult.